221 related articles for article (PubMed ID: 18760380)
1. Psychotropic agents in functional gastrointestinal disorders.
Grover M; Drossman DA
Curr Opin Pharmacol; 2008 Dec; 8(6):715-23. PubMed ID: 18760380
[TBL] [Abstract][Full Text] [Related]
2. Psychopharmacologic and behavioral treatments for functional gastrointestinal disorders.
Grover M; Drossman DA
Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):151-70, vii-viii. PubMed ID: 19232286
[TBL] [Abstract][Full Text] [Related]
3. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report.
Drossman DA; Tack J; Ford AC; Szigethy E; Törnblom H; Van Oudenhove L
Gastroenterology; 2018 Mar; 154(4):1140-1171.e1. PubMed ID: 29274869
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants for functional gastrointestinal disorders in children.
Tan E; Smith CH; Goldman RD
Can Fam Physician; 2013 Mar; 59(3):263-4. PubMed ID: 23486795
[TBL] [Abstract][Full Text] [Related]
5. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?
Westenberg HG
J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918
[TBL] [Abstract][Full Text] [Related]
6. [Neurobiology and pharmacotherapy of social phobia].
Aouizerate B; Martin-Guehl C; Tignol J
Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
[TBL] [Abstract][Full Text] [Related]
7. Use of neurotransmitter regulators in functional gastrointestinal disorders based on symptom analysis.
Luo QQ; Chen SL
J Dig Dis; 2017 Apr; 18(4):203-206. PubMed ID: 28371414
[TBL] [Abstract][Full Text] [Related]
8. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
Thorkelson G; Bielefeldt K; Szigethy E
Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
[TBL] [Abstract][Full Text] [Related]
9. Neurotropic and psychotropic drugs in dermatology.
Tennyson H; Levine N
Dermatol Clin; 2001 Jan; 19(1):179-97, x. PubMed ID: 11155582
[TBL] [Abstract][Full Text] [Related]
10. The use of antidepressants in functional gastrointestinal disorders: new uses for old drugs.
Olden KW
CNS Spectr; 2005 Nov; 10(11):891-6. PubMed ID: 16273017
[TBL] [Abstract][Full Text] [Related]
11. The use of psychotropic drugs in irritable bowel syndrome.
Dekel R; Drossman DA; Sperber AD
Expert Opin Investig Drugs; 2013 Mar; 22(3):329-39. PubMed ID: 23316916
[TBL] [Abstract][Full Text] [Related]
12. Psychotropics, Antidepressants, and Visceral Analgesics in Functional Gastrointestinal Disorders.
Törnblom H; Drossman DA
Curr Gastroenterol Rep; 2018 Nov; 20(12):58. PubMed ID: 30397821
[TBL] [Abstract][Full Text] [Related]
13. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease.
Mayer EA; Tillisch K; Bradesi S
Aliment Pharmacol Ther; 2006 Sep; 24(6):919-33. PubMed ID: 16948804
[TBL] [Abstract][Full Text] [Related]
14. Current concepts in functional gastrointestinal disorders.
Kovacic K
Curr Opin Pediatr; 2015 Oct; 27(5):619-24. PubMed ID: 26208234
[TBL] [Abstract][Full Text] [Related]
15. Central Neuromodulators for Treating Functional GI Disorders: A Primer.
Sobin WH; Heinrich TW; Drossman DA
Am J Gastroenterol; 2017 May; 112(5):693-702. PubMed ID: 28349992
[TBL] [Abstract][Full Text] [Related]
16. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.
Dell'Osso B; Palazzo MC; Oldani L; Altamura AC
CNS Neurosci Ther; 2011 Dec; 17(6):723-32. PubMed ID: 21155988
[TBL] [Abstract][Full Text] [Related]
17. Further strategies for treating fibromyalgia: the role of serotonin and norepinephrine reuptake inhibitors.
Mease PJ
Am J Med; 2009 Dec; 122(12 Suppl):S44-55. PubMed ID: 19962496
[TBL] [Abstract][Full Text] [Related]
18. Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy.
Dell'Osso B; Buoli M; Baldwin DS; Altamura AC
Hum Psychopharmacol; 2010 Jan; 25(1):17-29. PubMed ID: 20041476
[TBL] [Abstract][Full Text] [Related]
19. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM
Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706
[TBL] [Abstract][Full Text] [Related]
20. [Serotonin-norepinephrine reuptake inhibitors in psychiatry and neurology].
Sivolap YP
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(8):141-146. PubMed ID: 34481450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
